PATENT CLAIM ANALYSIS

Application Number: 16277367
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "221000"]

Abstract:
A method of reducing convulsive seizure frequency in a human patient diagnosed with Dravet syndrome, comprising administering to the patient a therapeutically effective dose of fenfluramine or a pharmaceutically acceptable salt, base, acid or amine thereof, and repeating the administering over a period of days until the patient exhibits a significant reduction (e.g., 40% or greater) from baseline in convulsive seizure frequency. In some embodiments of the method, convulsive seizures are completely eliminated for 10 days or more, 20 days or more, 30 days or more, 50 days or more, 100 days or more.

Claim (Index 19):
The method of  claim 18  wherein the patient is about 2 years of age.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.70312
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16193812', '15429646', '13887014', '14447253', '15003161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8124891870399957
- 35 USC 102 Novelty (BERT): 0.5298453528341719
- Combined Prediction Score: 0.7842248036194134
- Mean Citation Score: 353.53957
- Max Citation Score: 358.1037
- Similarity Product: 303.43857302309283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test